GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Shandong Lukang Pharmaceutical Co Ltd (SHSE:600789) » Definitions » EV-to-Revenue

Shandong Lukang Pharmaceutical Co (SHSE:600789) EV-to-Revenue : 1.54 (As of May. 09, 2024)


View and export this data going back to 1997. Start your Free Trial

What is Shandong Lukang Pharmaceutical Co EV-to-Revenue?

EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Shandong Lukang Pharmaceutical Co's enterprise value is ¥9,678 Mil. Shandong Lukang Pharmaceutical Co's Revenue for the trailing twelve months (TTM) ended in Mar. 2024 was ¥6,276 Mil. Therefore, Shandong Lukang Pharmaceutical Co's EV-to-Revenue for today is 1.54.

The historical rank and industry rank for Shandong Lukang Pharmaceutical Co's EV-to-Revenue or its related term are showing as below:

SHSE:600789' s EV-to-Revenue Range Over the Past 10 Years
Min: 1.12   Med: 2.04   Max: 6.16
Current: 1.61

During the past 13 years, the highest EV-to-Revenue of Shandong Lukang Pharmaceutical Co was 6.16. The lowest was 1.12. And the median was 2.04.

SHSE:600789's EV-to-Revenue is ranked better than
65.69% of 1026 companies
in the Drug Manufacturers industry
Industry Median: 2.4 vs SHSE:600789: 1.61

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

As of today (2024-05-09), Shandong Lukang Pharmaceutical Co's stock price is ¥9.11. Shandong Lukang Pharmaceutical Co's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2024 was ¥7.07. Therefore, Shandong Lukang Pharmaceutical Co's PS Ratio for today is 1.29.


Shandong Lukang Pharmaceutical Co EV-to-Revenue Historical Data

The historical data trend for Shandong Lukang Pharmaceutical Co's EV-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shandong Lukang Pharmaceutical Co EV-to-Revenue Chart

Shandong Lukang Pharmaceutical Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.99 2.37 1.80 1.56 1.40

Shandong Lukang Pharmaceutical Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
EV-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.38 1.28 1.33 1.40 1.21

Competitive Comparison of Shandong Lukang Pharmaceutical Co's EV-to-Revenue

For the Drug Manufacturers - Specialty & Generic subindustry, Shandong Lukang Pharmaceutical Co's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Shandong Lukang Pharmaceutical Co's EV-to-Revenue Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Shandong Lukang Pharmaceutical Co's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where Shandong Lukang Pharmaceutical Co's EV-to-Revenue falls into.



Shandong Lukang Pharmaceutical Co EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

Shandong Lukang Pharmaceutical Co's EV-to-Revenue for today is calculated as:

EV-to-Revenue=Enterprise Value (Today)/Revenue (TTM)
=9678.171/6275.642
=1.54

Shandong Lukang Pharmaceutical Co's current Enterprise Value is ¥9,678 Mil.
Shandong Lukang Pharmaceutical Co's Revenue for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥6,276 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Shandong Lukang Pharmaceutical Co  (SHSE:600789) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

Shandong Lukang Pharmaceutical Co's PS Ratiofor today is calculated as:

PS Ratio=Share Price (Today)/Revenue per Share (TTM)
=9.11/7.07
=1.29

Shandong Lukang Pharmaceutical Co's share price for today is ¥9.11.
Shandong Lukang Pharmaceutical Co's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥7.07.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Shandong Lukang Pharmaceutical Co EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of Shandong Lukang Pharmaceutical Co's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Shandong Lukang Pharmaceutical Co (SHSE:600789) Business Description

Traded in Other Exchanges
N/A
Address
No. 152 Taibai West Road, Jining, Shandong, CHN, 272021
Shandong Lukang Pharmaceutical Co Ltd is a bio-pharmaceuticals company. It is engaged in manufacturing antibiotics, semi-synthetic antibiotics for human use, bio-pharmaceuticals for veterinary and agriculture use, intermediates, resins, starches, glucose and amino acids.

Shandong Lukang Pharmaceutical Co (SHSE:600789) Headlines

No Headlines